Advertisement

Reactions Weekly

, Volume 1779, Issue 1, pp 139–139 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Immune-related adverse events: 60 case reports
Case report
  • 66 Downloads

Reference

  1. Kaur A, et al. Immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: A single-center experience. Medicine 98: e17348, No. 41, Oct 2019. Available from: URL: http://doi.org/10.1097/MD.0000000000017348 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations